Cyclacel Pharmaceuticals Reports Third Quarter 2018 Financial Results
November 12, 2018 16:05 ET
|
Cyclacel
Conference Call Scheduled November 12, 2018 at 4:30 p.m. ET BERKELEY HEIGHTS, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the...
Cyclacel Pharmaceuticals to Release Third Quarter 2018 Financial Results
November 06, 2018 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Cyclacel Pharmaceuticals to Present at the Dawson James Small Cap Growth Conference
October 23, 2018 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Cyclacel Pharmaceuticals to Present at the Ladenburg Thalmann 2018 Healthcare Conference
September 26, 2018 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Cyclacel Pharmaceuticals Appoints Robert J. Spiegel, M.D. to Board of Directors
September 12, 2018 07:00 ET
|
Cyclacel
- Former CMO of Schering-Plough Joins Cyclacel Board - BERKELEY HEIGHTS, N.J., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the...
Cyclacel Pharmaceuticals to Present at the 20th Annual H.C. Wainwright Global Investment Conference
August 29, 2018 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Cyclacel Pharmaceuticals Reports Second Quarter 2018 Financial Results
August 09, 2018 16:05 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Cyclacel Pharmaceuticals to Release Second Quarter 2018 Financial Results
August 01, 2018 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral...
Cyclacel Pharmaceuticals Reports First Quarter 2018 Financial Results
May 14, 2018 16:05 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., May 14, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral...
Cyclacel Pharmaceuticals to Release First Quarter 2018 Financial Results
May 08, 2018 07:00 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., May 08, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral...